MGAT4EP and breast carcinoma: Our analysis showed that the expression of MGAT4EP was significantly higher in patients with T4 stage breast cancer compared to those with T1, T2, or T3 stages (T4 vs T1, p = .003; T4 vs T2/T3, p = .013) (Figure 2a).